Literature DB >> 2702638

Expression of a folate binding protein in L1210 cells grown in low folate medium.

G Jansen1, I Kathmann, B C Rademaker, B J Braakhuis, G R Westerhof, G Rijksen, J H Schornagel.   

Abstract

We have isolated variants of L1210 cells (L1210B) expressing, in addition to the "classical" high affinity/low capacity system for reduced folate uptake, high levels of a membrane-associated folate binding protein. This folate binding protein was expressed in L1210 cells grown at low physiological folate levels (less than 0.5 nM), but down-regulated after transfer in standard high folate (2 microM) medium. The binding capacity of L1210B cells for [3H]folic acid and [3H]-methotrexate was identical (5-11 pmol/10(6) cells) but affinities were different. The affinities relative to folic acid were 0.5 for 5-methyltetrahydrofolate, 0.25 for 5-formyltetrahydrofolate, 0.08 for 10-ethyl-10-deazaaminopterin, and 0.05 for methotrexate, respectively. L1210B cells exposed to low extracellular concentrations of [3H]folic acid (25 nM) accumulated 15 pmol [3H]folic acid/10(7) cells over a 5-h period. [3H]Folic acid accumulation by wild-type L1210 cells could not be demonstrated under these conditions. The folate binding protein in L1210B cells could be specifically and covalently labeled at 4 degrees C with a N-hydroxysuccinimide ester of [3H]-methotrexate or [3H]folic acid. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of detergent-solubilized membrane proteins showed a major labeled band with Mr 42,000-44,000.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702638

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Growth-inhibitory effects of 5,10-dideazatetrahydrofolic acid on variant murine L1210 and human CCRF-CEM leukemia cells with different membrane-transport characteristics for (anti)folate compounds.

Authors:  G Jansen; G R Westerhof; I Kathmann; G Rijksen; J H Schornagel
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Regulation of the cytoplasmic accumulation of 5-methyltetrahydrofolate in MA104 cells is independent of folate receptor regulation.

Authors:  B A Kamen; C A Johnson; M T Wang; R G Anderson
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

3.  Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.

Authors:  K N Chung; Y Saikawa; T H Paik; K H Dixon; T Mulligan; K H Cowan; P C Elwood
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  Transfection of a glycosylated phosphatidylinositol-anchored folate-binding protein complementary DNA provides cells with the ability to survive in low folate medium.

Authors:  C A Luhrs; C A Raskin; R Durbin; B Wu; E Sadasivan; W McAllister; S P Rothenberg
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines.

Authors:  Lilah Rothem; Ilan Ifergan; Yotam Kaufman; David G Priest; Gerrit Jansen; Yehuda G Assaraf
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

6.  Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions.

Authors:  Aśok Antony; Ying-Sheng Tang; Rehana A Khan; Mangatt P Biju; Xiangli Xiao; Qing-Jun Li; Xin-Lai Sun; Hiremagalur N Jayaram; Sally P Stabler
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

7.  Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines.

Authors:  Jimmy W Crott; Zhenhua Liu; Mary K Keyes; Sang-Woon Choi; Hyeran Jang; Mary P Moyer; Joel B Mason
Journal:  J Nutr Biochem       Date:  2007-08-03       Impact factor: 6.048

8.  Chemical and genetic validation of dihydrofolate reductase-thymidylate synthase as a drug target in African trypanosomes.

Authors:  Natasha Sienkiewicz; Szymon Jarosławski; Susan Wyllie; Alan H Fairlamb
Journal:  Mol Microbiol       Date:  2008-07       Impact factor: 3.501

9.  Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid.

Authors:  E Erba; S Sen; C Sessa; F L Vikhanskaya; M D'Incalci
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

10.  Endocytosis of GPI-linked membrane folate receptor-alpha.

Authors:  S Rijnboutt; G Jansen; G Posthuma; J B Hynes; J H Schornagel; G J Strous
Journal:  J Cell Biol       Date:  1996-01       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.